News

Merck & Co.'s peptides could be undergoing a transformation into oral tablets thanks to a $493 million licensing deal the ...
a global pharmaceutical company focusing on scientific and technological innovation, announced on March 25 that it has entered into an exclusive license agreement with United States-based Merck, ...
Chainsaw provides a powerful ‘first-response’ capability to quickly identify threats within Windows forensic artefacts such as Event Logs and the MFT file. Chainsaw offers a generic and fast method of ...
turn back towards the building and climb in through its open window. The Artefact (See Also: The Last of Us 2: All Artefacts Locations) is on the table.
The Sheffield Blitz Memorial Trust is calling on the public to help bring history to life by loaning treasured artefacts, family heirlooms, and memorabilia related to the Sheffield Blitz.
Merck's stock trades at a low valuation as investors worry about Keytruda's looming patent cliff. The company is looking to a new, subcutaneous formulation, which could help sales remain strong ...
Trump has announced 25% tariffs on cars and car parts imported into the US US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was ...
US President Donald Trump has again singled out Ireland's pharmaceutical industry as a target for tariffs. Trump was speaking as he announced 25% tariffs on cars and car parts imported into the US.
Some scientists assigned double the number of new product applications for review Some deadlines for tobacco products will not be met and the start of new applications have been delayed, scientist ...
Data on federal individual contributions downloaded from the Federal Election Commission on 02/06/2025. State and local contributions are uploaded on a rolling basis. Federal law prohibits the use of ...
40% of Merck & Co., Inc.'s revenues are driven by cancer med Keytruda, which faces patent expiry by 2028, posing a significant risk to future earnings and share price value. The company is ...